A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection

NCT05801835 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: (cytarabine: daunorubicin) liposome for injection
DRUG: Vyxeos
DRUG: (cytarabine: daunorubicin) liposome for injection
DRUG: Vyxeos

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.